Jake7 schreef op 16 januari 2019 19:16:
October 12, 2018 01:00 ET | Source: Kiadis Pharma N. V.
" The Company is on track with the ongoing Phase 3 clinical study to enroll 250 patients at leading transplant centers globally. The Company has now enrolled 22 patients and has 14 sites open in 7 countries. Kiadis Pharma expects to have over
20 sites open by the end of 2018, including several US sites. "
Ik kan nergens info vinden over US sites, of heb ik ergens iets gemist ?